Search

Author/Creator Boullerot, Laura

1. Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy. Issue 7 (6th July 2021)

Authors:
Lauret Marie Joseph, Elodie; Kirilovsky, Amos; Lecoester, Benoît; El Sissy, Carine; Boullerot, Laura; Rangan, Laurie; Marguier, Amélie; Tochet, Florent; Dosset, Magalie; Boustani, Jihane; Ravel, Patrice; Boidot, Romain; Spehner, Laurie; Haicheur-Adjouri, Nacilla; Marliot, Florence; Pallandre, Jea...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 7(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer. (1st February 2019)

Authors:
Picard, Emilie; Godet, Yann; Laheurte, Caroline; Dosset, Magalie; Galaine, Jeanne; Beziaud, Laurent; Loyon, Romain; Boullerot, Laura; Lauret Marie Joseph, Elodie; Spehner, Laurie; Jacquin, Marion; Eberst, Guillaume; Gaugler, Béatrice; Le pimpec-Barthes, Françoise; Fabre, Elizabeth; Westeel, Virgi...
Journal:
Oncoimmunology
Issue:
Volume 8:Number 2(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Metronomic cyclophosphamide induces regulatory T cells depletion and PSA‐specific T cells reactivation in patients with biochemical recurrent prostate cancer. Issue 4 (11th December 2019)

Authors:
Laheurte, Caroline; Thiery‐Vuillemin, Antoine; Calcagno, Fabien; Legros, Anna; Simonin, Harmonie; Boullerot, Laura; Jacquin, Marion; Nguyen, Thierry; Mouillet, Guillaume; Borg, Christophe; Adotévi, Olivier
Journal:
International journal of cancer
Issue:
Volume 147:Issue 4(2020)
Page Start:
1199
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy. Issue 11 (1st October 2018)

Authors:
Beziaud, Laurent; Boullerot, Laura; Tran, Thi; Mansi, Laura; Marie‐Joseph, Elodie Lauret; Ravel, Patrice; Johannes, Ludger; Bayry, Jagadeesh; Tartour, Eric; Adotévi, Olivier
Journal:
International journal of cancer
Issue:
Volume 143:Issue 11(2018)
Page Start:
3008
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide–Based Vaccine in Patients With Refractory Advanced Non–Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study. Issue 2 (7th September 2022)

Authors:
Adotévi, Olivier; Vernerey, Dewi; Jacoulet, Pascale; Meurisse, Aurélia; Laheurte, Caroline; Almotlak, Hamadi; Jacquin, Marion; Kaulek, Vincent; Boullerot, Laura; Malfroy, Marine; Orillard, Emeline; Eberst, Guillaume; Lagrange, Aurélie; Favier, Laure; Gainet-Brun, Marie; Doucet, Ludovic; Teixeira,...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 2(2023)
Page Start:
373
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts. (3rd April 2018)

Authors:
Kroemer, Marie; Spehner, Laurie; Mercier-Letondal, Patricia; Boullerot, Laura; Kim, Stefano; Jary, Marine; Galaine, Jeanne; Picard, Emilie; Ferrand, Christophe; Nguyen, Thierry; Larosa, Fabrice; Adotévi, Olivier; Godet, Yann; Borg, Christophe
Journal:
Oncoimmunology
Issue:
Volume 7:Number 4(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗